1. Academic Validation
  2. Cerium-Organic Framework and Resveratrol Composite Hydrogel Scaffold with Dual Antioxidant Activity for Enhanced Bone Regeneration

Cerium-Organic Framework and Resveratrol Composite Hydrogel Scaffold with Dual Antioxidant Activity for Enhanced Bone Regeneration

  • ACS Appl Mater Interfaces. 2025 Jun 4;17(22):31828-31842. doi: 10.1021/acsami.5c01679.
Yao Lu 1 Lan Zhang 2 Bin Yang 1 Hansheng Hu 1 Hao Sun 1 Dan Guo 1
Affiliations

Affiliations

  • 1 Department of Orthopedic, Northern Jiangsu People's Hospital Affiliated Hospital to Yangzhou University, Yangzhou 225009, China.
  • 2 Department of Orthopedic, Soochow University, Suzhou 215006, China.
Abstract

The repair of large bone defects remains a significant challenge in the field of orthopedics, as traditional bone substitutes face issues such as limited supply and structural incompatibility. Therefore, the development of novel biomaterials to promote bone repair is of great significance. This study proposes a composite material based on a gelatin/alginate dual-network hydrogel scaffold (Gel/AlgMA), which regulates oxidative stress in the local microenvironment of bone defects by loading cerium metal-organic frameworks (Ce-UiO-66) and resveratrol (Res). The cerium ions in Ce-UiO-66 exhibit excellent antioxidant properties in their multivalent states, capable of scavenging excess Reactive Oxygen Species (ROS), improving mitochondrial function, and enhancing stability through a polydopamine (PDA) coating. The Gel/Alg@Ce-Res/PDA composite scaffold was prepared via photopolymerization and its in vitro biocompatibility, antioxidant properties, and osteogenic potential were evaluated. The results indicated that the composite scaffold effectively scavenged ROS, alleviated oxidative stress, and promoted the proliferation and differentiation of osteoblasts. Moreover, in vivo experiments further confirmed the favorable effects of the Gel/Alg@Ce-Res/PDA scaffold in bone defect repair. This study provides an innovative biomaterial design for bone defect treatment, with promising clinical application prospects.

Keywords

Ce-UiO-66; bone defect; composite scaffold; osteogenesis; oxidative stress.

Figures
Products
Inhibitors & Agonists
Other Products